CIK 0001590560
- Large accelerated filer
uniQure N.V.
Sign in to watch- Ticker
- QURE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 339-970-7000
- Business address
- PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
- Former names
- uniQure B.V.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $192,950
- in 1 filing, $193K under 10b5-1 plans
Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-13 | Soteropoulos Paula Director | Grant or award · Stock Option (Right to Buy) | +17,060 | 17,060 | ||
| 2023-06-13 | POST LEONARD E Director | Grant or award | +8,700 | 20,512 | ||
| 2023-06-13 | POST LEONARD E Director | Grant or award · Stock Option (Right to Buy) | +17,060 | 17,060 | ||
| 2023-06-13 | Meek David D. Director | Grant or award | +8,700 | 24,771 | ||
| 2023-06-13 | Meek David D. Director | Grant or award · Stock Option (Right to Buy) | +17,060 | 17,060 | ||
| 2023-06-13 | Kaye Jack Director | Grant or award | +8,700 | 36,399 | ||
| 2023-06-13 | Kaye Jack Director | Grant or award · Stock Option (Right to Buy) | +17,060 | 17,060 | ||
| 2023-06-13 | Gut Robert Director | Grant or award | +8,700 | 50,897 | ||
| 2023-06-13 | Gut Robert Director | Grant or award · Stock Option (Right to Buy) | +17,060 | 17,060 | ||
| 2023-06-13 | Balachandran Madhavan Director | Grant or award | +8,700 | 28,273 | ||
| 2023-06-13 | Balachandran Madhavan Director | Grant or award · Stock Option (Right to Buy) | +17,060 | 17,060 |
Page 13 of 13 · 251 trades